血液分离术市场规模、份额和成长分析（按产品、流程、技术、应用、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，血液分离术市场规模将达到 34.5 亿美元，到 2025 年将达到 38.3 亿美元，到 2033 年将达到 89.2 亿美元，在预测期（2026-2033 年）内，复合年增长率为 11.15%。

受多种疾病发病率上升和对安全血液成分需求成长的推动，血液分离术市场持续稳定扩张。技术进步催生了创新血液分离术，并提高了手术效率。支持性的报销政策和血液分离疗法的资金支持进一步推动了市场发展。此疗法已逐渐成为血栓性血小板低下紫斑症、溶血性尿毒症候群和自体免疫疾病等疾病的第一线和辅助治疗手段。新产品的不断推出显着影响市场成长前景。然而，训练有素的专业人员短缺、血液安全问题以及高昂的手术费用等挑战仍需解决，以维持市场成长动能。整体而言，血液分离术在临床应用中展现出巨大的潜力。

血液分离术市场驱动因素

慢性疾病（包括癌症、自体免疫疾病和心血管疾病）的日益普遍，显着推动了血液分离术的需求。血液分离术能够选择性地去除或收集特定的血液成分，对于有效管理这些健康问题至关重要。这种标靶治疗方法能够改善患者照护和治疗效果，使其成为对抗严重患者治疗方案中的关键组成部分。随着医疗专业人员寻求创新解决方案来应对复杂的医疗挑战，对个人化医疗和改善医疗保健管理策略的持续重视，进一步推动了血液分离术市场的成长。

血液分离术市场限制

由于设备和治疗流程高成本，血液分离术市场面临严峻挑战。购买和维护这些专业设备所需的大量资金投入，可能会阻碍医疗机构的广泛采用。此外，血液分离机的安装和操作也较为复杂，会阻碍市场扩张。雪上加霜的是，潜在捐血者对捐血分离术技术的认知度较低，这会导致参与率低，最终限制市场成长潜力。因此，这些因素共同限制了血液分离术产业的发展。

血液分离术市场趋势

血液分离术领域的关键市场趋势是个人化医疗和标靶治疗的日益普及。随着医疗技术的进步，人们越来越重视根据患者的个别特征（例如疾病状态、基因标记和治疗反应）来客製化治疗方案。这种个人化方法不仅能提高治疗效果，还能优化患者预后，进而提升医疗品质。此外，先进数据分析和生物标记识别技术的整合有望推动血液分离术技术的创新，并带动对能够针对各种疾病状态进行个人化治疗性介入的解决方案的需求。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析及其影响

关键市场考察

• 关键成功因素
• 竞争程度
• 监管环境
• 关键投资机会
• 市场吸引力指数
• 技术进步
• 市场生态系统
• 专利分析
• 价值链分析
• 案例研究分析
• 总体经济指标

全球血液分离市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 血液分离耗材
  • 离心式血液分离装置
  • 膜分离设备
• 血液分离机

全球血液分离术市场规模（按手术类型和复合年增长率划分）（2026-2033 年）

• 血浆置换疗法
• 血小板分离方法
• 红血球分离疗法
• 白血球分离法
• 光疗
• 低密度脂蛋白血浆置换术
• 其他的

全球血液分离术市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 离心
  • 连续流离失所
  • 间歇流离心
• 膜分离

全球血液分离术市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

• 肾臟疾病
• 神经病学
• 血液学
• 癌症
• 自体免疫疾病
• 心血管疾病
• 其他的

全球血液分离术市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 血液采集中心和血液成分供应商
• 医院及输血中心
• 其他的

全球血液分离术市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Terumo BCT, Inc.（Japan）
• Fresenius Medical Care（Germany）
• Haemonetics Corporation（United States）
• Baxter International（United States）
• Asahi Kasei Medical Co., Ltd.（Japan）
• Kaneka Corporation（Japan）
• Cerus Corporation（United States）
• B. Braun Melsungen AG（Germany）
• Macopharma SA（France）
• Kawasumi Laboratories（Japan）
• Nikkiso Co., Ltd（Japan）
• Medica SPA（Italy）
• Miltenyi Biotec（Germany）
• Otsuka Holdings（JIMRO）（Japan）
• Cytosorbents Corporation（United States）
• Bioelettronica Srl（Italy）
• Guangzhou Daji Medical（China）
• Beijing ZKSK Technology（China）
• Infomed SA（Switzerland）
• Haier Biomedical（China）

结论与建议

Apheresis Market size was valued at USD 3.45 Billion in 2024 and is poised to grow from USD 3.83 Billion in 2025 to USD 8.92 Billion by 2033, growing at a CAGR of 11.15% during the forecast period (2026-2033).

The apheresis market is witnessing robust expansion, fueled by an increasing incidence of various diseases and a growing need for safe blood components. Advances in technology are leading to the development of innovative apheresis techniques, enhancing procedural effectiveness. Supportive reimbursement policies and funding for apheresis treatments further bolster market dynamics. This therapy is gaining traction as both a primary and adjunct treatment for conditions such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and autoimmune diseases. The continual introduction of new products significantly influences growth prospects. Nonetheless, challenges such as a shortage of trained professionals, concerns regarding blood safety, and high procedural costs need to be addressed to maintain the momentum of market growth. Overall, apheresis demonstrates promising potential in clinical applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Apheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Apheresis Market Segments Analysis

Global Apheresis Market is segmented by product, procedure, technology, application, end user and region. Based on Product, the market is segmented into Apheresis Disposals and Apheresis Devices. Based on Procedure, the market is segmented into Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, Photopheresis, LDL-apheresis, and Others. Based on technology, the market is segmented into Centrifugation, and Membrane Separation. Based on application, the market is segmented into Renal Diseases, Neurology, Haematology, Cancer, Autoimmune Diseases, Cardiovascular Diseases and others. Based on end user, the market is segmented into Blood Collection Centers & Blood Component Providers, Hospitals & Transfusion Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Apheresis Market

The increasing prevalence of chronic conditions, including cancer, autoimmune diseases, and cardiovascular disorders, significantly boosts the demand for apheresis procedures. Apheresis is essential for effectively managing these health issues, as it allows for the selective removal or collection of particular blood components. This targeted approach enhances patient care and treatment outcomes, making apheresis a vital component in the therapeutic landscape for individuals battling these serious illnesses. The ongoing emphasis on personalized medicine and improved health management strategies further supports the growth of the apheresis market, as healthcare providers seek innovative solutions to address complex medical challenges.

Restraints in the Apheresis Market

The apheresis market faces significant challenges due to the high costs linked to both the devices and the therapeutic procedures. The substantial financial investment needed for acquiring and maintaining these specialized devices can deter healthcare facilities from adopting them widely. Moreover, the complexities involved in the installation and operation of apheresis equipment may also impede market expansion. Compounding these issues is the limited awareness of apheresis techniques among potential blood donors, which can lead to a decline in participation, ultimately restricting the growth potential of the market. Thus, these factors collectively present considerable restraints on apheresis industry development.

Market Trends of the Apheresis Market

A significant market trend in the apheresis sector is the rising acceptance of personalized medicine and targeted therapies. As healthcare technology advances, there is an increasing focus on customizing treatments to align with individual patient needs, including their unique medical conditions, genetic markers, and responses to treatments. This personalized approach not only enhances therapeutic efficacy but also optimizes patient outcomes, resulting in improved care quality. Furthermore, the integration of advanced data analytics and biomarker identification is likely to propel innovation in apheresis technologies, driving demand for solutions that facilitate tailored therapeutic interventions across various medical conditions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Regulatory Landscape
• Top Investment Pockets
• Market Attractiveness Index
• Technology Advancement
• Market Ecosystem
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Macro-Economic Indicators

Global Apheresis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Apheresis Disposals
  • Centrifugal Apheresis Devices
  • Membrane Separators
• Apheresis Devices

Global Apheresis Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Plasmapheresis
• Plateletpheresis
• Erythrocytapheresis
• Leukapheresis
• Photopheresis
• LDL-apheresis
• Others

Global Apheresis Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Centrifugation
  • Continuous Flow Centrifugal
  • Intermittent Flow Centrifugation
• Membrane Separation

Global Apheresis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Renal Diseases
• Neurology
• Haematology
• Cancer
• Autoimmune Diseases
• Cardiovascular Diseases
• Others

Global Apheresis Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Blood Collection Centers & Blood Component Providers
• Hospitals & Transfusion Centers
• Others

Global Apheresis Market Size & CAGR (2026-2033)

• North America (Product, Procedure, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Procedure, Technology, Application, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Procedure, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Procedure, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Terumo BCT, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica SPA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings (JIMRO) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytosorbents Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioelettronica S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guangzhou Daji Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing ZKSK Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infomed SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haier Biomedical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation